Cell proliferation gene plays a distinct role in cells that no longer proliferate
In a tale of identities as divergent as “The Prince and the Pauper,” a well-known cancer-causing gene also…
Scallop-derived plasmalogens may support brain health and memory
The study, funded by B&S Corporation Co., Ltd., which manufactures and markets scallop plasmalogen, evaluated memory and brain…
Laser treatment may extend survival in glioblastoma patients
For patients facing a diagnosis of glioblastoma – one of the most aggressive and devastating forms of brain…
Circadian Oncology: Timing, Cancer Treatment, and Patient Outcomes
IntroductionCircadian regulation in cancer biologyThe promise and challenges of cancer chronotherapyThe future of circadian medicine in cancer careReferencesFurther…
Integrated nanomaterials offer new strategies for cancer immunotherapy
Immune checkpoint inhibitors, cancer vaccines and cellular therapies have reshaped oncology, yet most patients still do not achieve…
Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer
Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the publication of a collaborative…
Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancer
A combination of two immunotherapy drugs showed encouraging activity when added to standard chemotherapy given prior to surgery…
Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study
Adult B-ALL exhibits significant heterogeneity and poor prognosis compared with the pediatric population. While the complete remission (CR)…
Engineered probiotic bacteria boost immune attack against pancreatic cancer
Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to treat. One major…
Oral drug avatrombopag reduces chemotherapy treatment delays, trial finds
In a phase 2 trial of patients with gastrointestinal cancers, avatrombopag helped 70% of those receiving chemotherapy to…
Bifidobacterium-based oral vaccine enhances anti-tumor immunity in clinical study
A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity. In an exploratory phase I…
New consensus provides updated guidance for managing prolactinoma tumors
Prolactinomas are the most common functional pituitary neuroendocrine tumors, accounting for nearly half of all hormone-secreting pituitary adenomas.…